The Prospect and Challenges to the Flow of Liquid Biopsy in Africa
AbstractLiquid biopsy technologies have the potential to transform cancer patient management as it offers non-invasive diagnosis and real-time monitoring of disease progression and treatment responses. The use of liquid biopsy for non-invasive cancer diagnosis can have pivotal importance for the African continent where access to medical infrastructures is limited, as it eliminates the need for surgical biopsies. To apply liquid biopsy technologies in the African setting, the influence of environmental and population genetic factors must be known. In this review, we discuss the use of circulating tumor cells, cell-free nucleic acids, extracellular vesicles, protein, and other biomolecules in liquid biopsy technology for cancer management with special focus on African studies. We discussed the prospect, barriers, and other aspects that pose challenges to the use of liquid biopsy in the African continent. View Full-Text
Share & Cite This Article
Temilola, D.O.; Wium, M.; Coulidiati, T.H.; Adeola, H.A.; Carbone, G.M.; Catapano, C.V.; Zerbini, L.F. The Prospect and Challenges to the Flow of Liquid Biopsy in Africa. Cells 2019, 8, 862.
Temilola DO, Wium M, Coulidiati TH, Adeola HA, Carbone GM, Catapano CV, Zerbini LF. The Prospect and Challenges to the Flow of Liquid Biopsy in Africa. Cells. 2019; 8(8):862.Chicago/Turabian Style
Temilola, Dada O.; Wium, Martha; Coulidiati, Tangbadioa H.; Adeola, Henry A.; Carbone, Giuseppina M.; Catapano, Carlo V.; Zerbini, Luiz F. 2019. "The Prospect and Challenges to the Flow of Liquid Biopsy in Africa." Cells 8, no. 8: 862.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.